PD-1 Inhibitor Intraperitoneal Perfusion Combined With PRaG Therapy for Malignant Ascites

Condition:   Malignant Ascites Interventions:   Drug: Serplulimab;   Drug: Molgramostim;   Radiation: Hypofractionated radiotherapy/Sterotactic body radiotherapy Sponsor:   Second Affiliated Hospital of Soochow University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials